OptiBiotix Health PLC
LSE:OPTI
Income Statement
Earnings Waterfall
OptiBiotix Health PLC
Income Statement
OptiBiotix Health PLC
| Jul-2009 | Jan-2010 | Jul-2010 | Jan-2011 | Jan-2012 | Jul-2012 | Jan-2013 | May-2014 | Nov-2014 | May-2015 | Nov-2015 | May-2016 | Nov-2016 | May-2017 | Nov-2017 | May-2018 | Nov-2018 | May-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+326%
|
0
+140%
|
0
-5%
|
0
-30%
|
0
+3%
|
1
+161%
|
1
+13%
|
1
+28%
|
1
+100%
|
2
+2%
|
2
+22%
|
2
+31%
|
2
-9%
|
2
-18%
|
0
-75%
|
1
+51%
|
1
-7%
|
1
-12%
|
1
+53%
|
1
+32%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+326%
|
0
+108%
|
0
-20%
|
0
-41%
|
0
+2%
|
0
+193%
|
0
+5%
|
0
+6%
|
1
+76%
|
1
+28%
|
1
+20%
|
1
+31%
|
1
-19%
|
1
-8%
|
0
-76%
|
0
+39%
|
0
-6%
|
0
-15%
|
0
+21%
|
1
+58%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(4)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
2
|
1
|
(2)
|
(3)
|
(3)
|
11
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
0
|
(0)
|
14
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-33%
|
(0)
N/A
|
(0)
-100%
|
(0)
-463%
|
(0)
+33%
|
(4)
-1 120%
|
(0)
+98%
|
(0)
-715%
|
(1)
-92%
|
(1)
-51%
|
(2)
-14%
|
(2)
+6%
|
(2)
-17%
|
(2)
-19%
|
(2)
+0%
|
(1)
+29%
|
(1)
+1%
|
(2)
-33%
|
(3)
-40%
|
(1)
+60%
|
3
N/A
|
3
-13%
|
(1)
N/A
|
(2)
-61%
|
(2)
-13%
|
11
N/A
|
(2)
N/A
|
(2)
-18%
|
(2)
-13%
|
(3)
-16%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
(0)
|
(5)
|
(0)
|
(1)
|
(0)
|
(0)
|
3
|
18
|
0
|
8
|
8
|
(9)
|
(25)
|
(0)
|
(1)
|
0
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
0
|
(0)
|
0
|
4
|
0
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-100%
|
(0)
N/A
|
(0)
-100%
|
(0)
-463%
|
(4)
-796%
|
(4)
+9%
|
(0)
+98%
|
(1)
-1 323%
|
(1)
-53%
|
(1)
-9%
|
(2)
-14%
|
(2)
+6%
|
2
N/A
|
2
-27%
|
(3)
N/A
|
(2)
+26%
|
(2)
-4%
|
(2)
-23%
|
(3)
-25%
|
6
N/A
|
21
+261%
|
17
-20%
|
6
-63%
|
2
-71%
|
2
+38%
|
(13)
N/A
|
(2)
+85%
|
(3)
-46%
|
(2)
+38%
|
(0)
+87%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(4)
|
(4)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
2
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
6
|
21
|
17
|
6
|
2
|
3
|
(13)
|
(2)
|
(3)
|
(2)
|
(0)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-100%
|
(0)
N/A
|
(0)
-100%
|
(0)
-463%
|
(4)
-796%
|
(4)
+9%
|
(0)
+98%
|
(1)
-1 251%
|
(1)
-55%
|
(1)
-2%
|
(1)
-9%
|
(1)
+7%
|
3
N/A
|
2
-25%
|
(2)
N/A
|
(2)
+19%
|
(2)
-7%
|
(2)
-15%
|
(3)
-26%
|
6
N/A
|
21
+256%
|
17
-19%
|
6
-62%
|
6
-6%
|
3
-56%
|
(13)
N/A
|
(2)
+85%
|
(3)
-46%
|
(2)
+39%
|
(0)
+89%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.06
-100%
|
-0.06
N/A
|
-0.14
-133%
|
-2.26
-1 514%
|
-16.79
-643%
|
-8.92
+47%
|
-0.01
+100%
|
-0.03
-200%
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
0.03
N/A
|
0.02
-33%
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
0.06
N/A
|
0.21
+250%
|
0.19
-10%
|
0.07
-63%
|
0.06
-14%
|
0.03
-50%
|
-0.15
N/A
|
-0.02
+87%
|
-0.03
-50%
|
-0.02
+33%
|
0
N/A
|
|